Evaluation in alcohol use disorders - insights from the nalmefene experience

Item

http://www.wikidata.org/entity/Q42348636

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Evaluation in alcohol use disorders - insights from the nalmefene experience

@en

Evaluation in alcohol use disorders - insights from the nalmefene experience

@nl

type

Item

label

Evaluation in alcohol use disorders - insights from the nalmefene experience

@en

Evaluation in alcohol use disorders - insights from the nalmefene experience

@nl

prefLabel

Evaluation in alcohol use disorders - insights from the nalmefene experience

@en

Evaluation in alcohol use disorders - insights from the nalmefene experience

@nl

P1476

Evaluation in alcohol use disorders - insights from the nalmefene experience

@en

P2093

Bruno Laviolle

http://www.w3.org/2001/XMLSchema#string

Clément Palpacuer

http://www.w3.org/2001/XMLSchema#string

Rémy Boussageon

http://www.w3.org/2001/XMLSchema#string

P2860

Managed alcohol as a harm reduction intervention for alcohol addiction in populations at high risk for substance abuse

Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials

Reduction of drinking in problem drinkers and all-cause mortality

The Effects of as-Needed Nalmefene on Patient-Reported Outcomes and Quality of Life in Relation to a Reduction in Alcohol Consumption in Alcohol-Dependent Patients

Methods to analyze treatment effects in the presence of missing data for a continuous heavy drinking outcome measure when participants drop out from treatment in alcohol clinical trials.

Nalmefene for the treatment of alcohol use disorders: recent data and clinical potential.

Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.

Efficacy and tolerability of naltrexone in the management of alcohol dependence.

The cost-effectiveness and public health benefit of nalmefene added to psychosocial support for the reduction of alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels: a Markov model.

Credibility of claims of subgroup effects in randomised controlled trials: systematic review.

P2888

s12916-016-0664-9

P304

119

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1186/S12916-016-0664-9

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Florian Naudet

P577

2016-08-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1028567143

http://www.w3.org/2001/XMLSchema#string

P698

27534932

http://www.w3.org/2001/XMLSchema#string

P921

alcohol consumption

P932

4989362

http://www.w3.org/2001/XMLSchema#string